Outcome determinants for Transformed Indolent Lymphomas treated with or without
Autologous Stem, Cell Transplantation, L. Munksgaard +3 more
Key Message: "The purpose of this work was to determine whether the outcome of patients with transformed indolent lymphoma improved if they, after R‐chemo, also received upfront autologous stem‐cell transplantation. Upfront autologous stem‐cell transplant improved the outcome in sequential, but not composite/discordant TIL. The beneficial impact of ASCT was greater in patients, who were rituximab‐naïve at transformation."